BeiGene opens phase one of $320M plant with 180 workers

9th October 2019 Uncategorised 0

In 2017 China’s BeiGene undertook two big deals. It licensed rights to a PD-1 inhibitor it is developing to Celegene and it kicked off construction of a $320 million manufacturing facility. While the Celgene deal has gotten off track, phase one of the plant is now complete. 

More: BeiGene opens phase one of 0M plant with 180 workers
Source: fierce